Literature DB >> 17996647

Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island.

Joy C Lin1, Shinwu Jeong, Gangning Liang, Daiya Takai, Merhnaz Fatemi, Yvonne C Tsai, Gerda Egger, Einav Nili Gal-Yam, Peter A Jones.   

Abstract

Epigenetic silencing of tumor suppressor genes is generally thought to involve DNA cytosine methylation, covalent modifications of histones, and chromatin compaction. Here, we show that silencing of the three transcription start sites in the bidirectional MLH1 promoter CpG island in cancer cells involves distinct changes in nucleosomal occupancy. Three nucleosomes, almost completely absent from the start sites in normal cells, are present on the methylated and silenced promoter, suggesting that epigenetic silencing may be accomplished by the stable placement of nucleosomes into previously vacant positions. Activation of the promoter by demethylation with 5-aza-2'-deoxycytidine involves nucleosome eviction. Epigenetic silencing of tumor suppressor genes may involve heritable changes in nucleosome occupancy enabled by cytosine methylation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996647      PMCID: PMC4657456          DOI: 10.1016/j.ccr.2007.10.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  50 in total

1.  Removal of promoter nucleosomes by disassembly rather than sliding in vivo.

Authors:  Hinrich Boeger; Joachim Griesenbeck; J Seth Strattan; Roger D Kornberg
Journal:  Mol Cell       Date:  2004-06-04       Impact factor: 17.970

2.  Genome-scale profiling of histone H3.3 replacement patterns.

Authors:  Yoshiko Mito; Jorja G Henikoff; Steven Henikoff
Journal:  Nat Genet       Date:  2005-09-11       Impact factor: 38.330

Review 3.  RNA meets chromatin.

Authors:  Emily Bernstein; C David Allis
Journal:  Genes Dev       Date:  2005-07-15       Impact factor: 11.361

4.  Genome-scale identification of nucleosome positions in S. cerevisiae.

Authors:  Guo-Cheng Yuan; Yuen-Jong Liu; Michael F Dion; Michael D Slack; Lani F Wu; Steven J Altschuler; Oliver J Rando
Journal:  Science       Date:  2005-06-16       Impact factor: 47.728

5.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

6.  Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability.

Authors:  Hiroaki Murata; Nada H Khattar; Yuna Kang; Liya Gu; Guo-Min Li
Journal:  Oncogene       Date:  2002-08-22       Impact factor: 9.867

7.  Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene.

Authors:  H Sasaki; P A Jones; J R Chaillet; A C Ferguson-Smith; S C Barton; W Reik; M A Surani
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

8.  Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.

Authors:  Jill A Fahrner; Sayaka Eguchi; James G Herman; Stephen B Baylin
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

9.  Cellular differentiation, cytidine analogs and DNA methylation.

Authors:  P A Jones; S M Taylor
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

10.  Coincident start sites for divergent transcripts at a randomly selected CpG-rich island of mouse.

Authors:  P Lavia; D Macleod; A Bird
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

View more
  85 in total

1.  Effects of DNA methylation on the structure of nucleosomes.

Authors:  Ju Yeon Lee; Tae-Hee Lee
Journal:  J Am Chem Soc       Date:  2011-12-15       Impact factor: 15.419

Review 2.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 3.  Functions of DNA methylation: islands, start sites, gene bodies and beyond.

Authors:  Peter A Jones
Journal:  Nat Rev Genet       Date:  2012-05-29       Impact factor: 53.242

4.  Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches.

Authors:  Elena Shumay; Joanna S Fowler
Journal:  Epigenetics       Date:  2010-05-05       Impact factor: 4.528

5.  Long-term stability of demethylation after transient exposure to 5-aza-2'-deoxycytidine correlates with sustained RNA polymerase II occupancy.

Authors:  Jacob D Kagey; Priya Kapoor-Vazirani; Michael T McCabe; Doris R Powell; Paula M Vertino
Journal:  Mol Cancer Res       Date:  2010-06-29       Impact factor: 5.852

Review 6.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

Review 7.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

8.  Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression.

Authors:  Vita Fedele; Fangping Dai; Anie P Masilamani; Dieter H Heiland; Eva Kling; Ana M Gätjens-Sanchez; Roberto Ferrarese; Leonardo Platania; Doostkam Soroush; Hyunsoo Kim; Sven Nelander; Astrid Weyerbrock; Marco Prinz; Andrea Califano; Antonio Iavarone; Markus Bredel; Maria S Carro
Journal:  Mol Cancer Res       Date:  2017-05-16       Impact factor: 5.852

9.  Activation of a Subset of Evolutionarily Young Transposable Elements and Innate Immunity Are Linked to Clinical Responses to 5-Azacytidine.

Authors:  Hitoshi Ohtani; Andreas D Ørskov; Alexandra S Helbo; Linn Gillberg; Minmin Liu; Wanding Zhou; Johanna Ungerstedt; Eva Hellström-Lindberg; Weili Sun; Gangning Liang; Peter A Jones; Kirsten Grønbæk
Journal:  Cancer Res       Date:  2020-04-03       Impact factor: 12.701

Review 10.  Targeting the cancer epigenome for therapy.

Authors:  Peter A Jones; Jean-Pierre J Issa; Stephen Baylin
Journal:  Nat Rev Genet       Date:  2016-09-15       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.